MILD试验十年结果:两年一次肺癌筛查安全有效
MILD试验将2376名筛查组参与者随机分为年度或两年一次低剂量CT筛查,中位筛查6.2年、随访23083人年。十年结果显示两年一次筛查与年度筛查的总死亡率和肺癌特异性死亡率相似,且减少随访CT数量,未增加晚期或间期肺癌。
要点
- 两年一次LDCT与年度LDCT的10年总死亡率(HR 0.80,95%CI 0.57-1.12)和肺癌特异性死亡率(HR 1.10,95%CI 0.59-2.05)相似。
- 基线LDCT阴性者两年一次筛查节省44%随访LDCT,全体参与者节省38%。
- 两年一次筛查未增加II-IV期或间期肺癌的发生。
核心结论
- 在基线检查阴性的受试者中,超过五年的两年一次LDCT筛查可达到与年度LDCT相当的肺癌死亡率降低效果。
研究设计与样本
- MILD试验为前瞻性随机试验,2005-2018年将2376名筛查组参与者随机分入年度LDCT组(n=1190)或两年一次LDCT组(n=1186)。
- 中位筛查期为6.2年,随访共23083人年。
主要发现
- 两年一次LDCT组与年度LDCT组相比,10年总死亡率HR为0.80(95%CI 0.57-1.12),肺癌特异性死亡率HR为1.10(95%CI 0.59-2.05)。
- 两年一次筛查在基线LDCT阴性者中节省44%的随访LDCT,在全体参与者中节省38%的LDCT。
- 两年一次筛查未增加II-IV期或间期肺癌的发生。
临床怎么用
- 对于基线LDCT阴性的受试者,可考虑采用两年一次LDCT筛查以降低筛查强度并节省医疗资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Multicentric Italian Lung Detection (MILD) trial demonstrated that prolonged low-dose computed tomography (LDCT) screening could achieve a 39% reduction in lung cancer (LC) mortality. We have here evaluated the long-term results of annual vs. biennial LDCT and the impact of screening intensity on overall and LC-specific mortality at 10 years. PATIENTS AND METHODS: Between 2005 and 2018, the MILD trial prospectively randomised the 2376 screening arm participants to annual (n = 1190) or biennial (n = 1186) LDCT, for a median screening period of 6.2 years and 23,083 person-years of follow-up. The primary outcomes were 10-year overall and LC-specific mortality, and the secondary end-points were the frequency of advanced-stage and interval LCs. RESULTS: The biennial LDCT arm showed a similar overall mortality (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.57-1.12) and LC-specific mortality at 10 years (HR 1.10, 95% CI 0.59-2.05), as compared with the annual LDCT arm. Biennial screening saved 44% of follow-up LDCTs in subjects with negative baseline LDCT, and 38% of LDCTs in all participants, with no increase in the occurrence of stage II-IV or interval LCs. CONCLUSIONS: The MILD trial provides original evidence that prolonged screening beyond five years with biennial LDCT can achieve an LC mortality reduction comparable to annual LDCT, in subjects with a negative baseline examination.
引用
- Pastorino U, Sverzellati N, Sestini S, et al. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening. Eur J Cancer. 2019. PMID: 31336289. doi:10.1016/j.ejca.2019.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。